Cargando…

Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole

Background. Carbapenem-resistant Enterobacteriaceae has increased dramatically in the last decade, resulting in infections that are difficult to treat and associated with high mortality rates. To prevent further antibacterial resistance, it is necessary to use carbapenem selectively. A combination o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikamo, Hiroshige, Yuasa, Akira, Wada, Keiko, Crawford, Bruce, Sugimoto, Naomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047423/
https://www.ncbi.nlm.nih.gov/pubmed/27704002
http://dx.doi.org/10.1093/ofid/ofw143
_version_ 1782457411858071552
author Mikamo, Hiroshige
Yuasa, Akira
Wada, Keiko
Crawford, Bruce
Sugimoto, Naomi
author_facet Mikamo, Hiroshige
Yuasa, Akira
Wada, Keiko
Crawford, Bruce
Sugimoto, Naomi
author_sort Mikamo, Hiroshige
collection PubMed
description Background. Carbapenem-resistant Enterobacteriaceae has increased dramatically in the last decade, resulting in infections that are difficult to treat and associated with high mortality rates. To prevent further antibacterial resistance, it is necessary to use carbapenem selectively. A combination of metronidazole with an antimicrobial agent active against aerobes is an alternative effective treatment for patients with complicated intra-abdominal infections (cIAIs). This study aimed to compare efficacy and safety of metronidazole combination therapies and carbapenem and to provide clinical evidence regarding the optimal treatment of cIAI. Methods. A systematic review and a meta-analysis of randomized clinical trials in the treatment of cIAI were conducted. The systematic review with PubMed, Embase, and the Cochrane Database of Systematic Reviews followed the Cochrane Handbook's recommended methodology, and the meta-analysis used a Mantel-Haenszel random-effects model with RevMan, version 5.3. Primary endpoints were clinical success and bacteriological eradication, and secondary endpoints were all-cause mortality and drug-related adverse events. Results. Eight studies comparing metronidazole combination therapies and carbapenem were included in the meta-analysis. No difference was found between combined therapy with metronidazole and carbapenem regarding clinical success (odds ratio [OR] = 1.31; 95% confidence interval [CI], .75–2.31), bacteriological eradication (OR = 1.27; 95% CI, .84–1.91), all-cause mortality (OR = 0.61; 95% CI, .37–1.00), or drug-related adverse events (OR = 0.58; 95% CI, .18–1.88). Sensitivity analyses found similar results. Conclusions. Combined therapy with metronidazole is as effective and safe as carbapenem in treatment of cIAI. Therefore, combined therapy with metronidazole offers an effective alternative to carbapenem with low risk of drug resistance.
format Online
Article
Text
id pubmed-5047423
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-50474232016-10-04 Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole Mikamo, Hiroshige Yuasa, Akira Wada, Keiko Crawford, Bruce Sugimoto, Naomi Open Forum Infect Dis Major Articles Background. Carbapenem-resistant Enterobacteriaceae has increased dramatically in the last decade, resulting in infections that are difficult to treat and associated with high mortality rates. To prevent further antibacterial resistance, it is necessary to use carbapenem selectively. A combination of metronidazole with an antimicrobial agent active against aerobes is an alternative effective treatment for patients with complicated intra-abdominal infections (cIAIs). This study aimed to compare efficacy and safety of metronidazole combination therapies and carbapenem and to provide clinical evidence regarding the optimal treatment of cIAI. Methods. A systematic review and a meta-analysis of randomized clinical trials in the treatment of cIAI were conducted. The systematic review with PubMed, Embase, and the Cochrane Database of Systematic Reviews followed the Cochrane Handbook's recommended methodology, and the meta-analysis used a Mantel-Haenszel random-effects model with RevMan, version 5.3. Primary endpoints were clinical success and bacteriological eradication, and secondary endpoints were all-cause mortality and drug-related adverse events. Results. Eight studies comparing metronidazole combination therapies and carbapenem were included in the meta-analysis. No difference was found between combined therapy with metronidazole and carbapenem regarding clinical success (odds ratio [OR] = 1.31; 95% confidence interval [CI], .75–2.31), bacteriological eradication (OR = 1.27; 95% CI, .84–1.91), all-cause mortality (OR = 0.61; 95% CI, .37–1.00), or drug-related adverse events (OR = 0.58; 95% CI, .18–1.88). Sensitivity analyses found similar results. Conclusions. Combined therapy with metronidazole is as effective and safe as carbapenem in treatment of cIAI. Therefore, combined therapy with metronidazole offers an effective alternative to carbapenem with low risk of drug resistance. Oxford University Press 2016-07-07 /pmc/articles/PMC5047423/ /pubmed/27704002 http://dx.doi.org/10.1093/ofid/ofw143 Text en © The Author 2016. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
spellingShingle Major Articles
Mikamo, Hiroshige
Yuasa, Akira
Wada, Keiko
Crawford, Bruce
Sugimoto, Naomi
Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole
title Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole
title_full Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole
title_fullStr Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole
title_full_unstemmed Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole
title_short Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole
title_sort optimal treatment for complicated intra-abdominal infections in the era of antibiotic resistance: a systematic review and meta-analysis of the efficacy and safety of combined therapy with metronidazole
topic Major Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047423/
https://www.ncbi.nlm.nih.gov/pubmed/27704002
http://dx.doi.org/10.1093/ofid/ofw143
work_keys_str_mv AT mikamohiroshige optimaltreatmentforcomplicatedintraabdominalinfectionsintheeraofantibioticresistanceasystematicreviewandmetaanalysisoftheefficacyandsafetyofcombinedtherapywithmetronidazole
AT yuasaakira optimaltreatmentforcomplicatedintraabdominalinfectionsintheeraofantibioticresistanceasystematicreviewandmetaanalysisoftheefficacyandsafetyofcombinedtherapywithmetronidazole
AT wadakeiko optimaltreatmentforcomplicatedintraabdominalinfectionsintheeraofantibioticresistanceasystematicreviewandmetaanalysisoftheefficacyandsafetyofcombinedtherapywithmetronidazole
AT crawfordbruce optimaltreatmentforcomplicatedintraabdominalinfectionsintheeraofantibioticresistanceasystematicreviewandmetaanalysisoftheefficacyandsafetyofcombinedtherapywithmetronidazole
AT sugimotonaomi optimaltreatmentforcomplicatedintraabdominalinfectionsintheeraofantibioticresistanceasystematicreviewandmetaanalysisoftheefficacyandsafetyofcombinedtherapywithmetronidazole